Cardiac Magnetic Resonance Evaluation of Myocardial Viability and Ischemia

Seminars in Roentgenology

Volumn 43, Issue 3, 2008, Pages 193-203

  Strzelczyk, Jacek ^a   Attili, Anil ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ARTICLE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CONTRAST MEDIA; DOBUTAMINE; ENDOCARDIUM; EXERCISE TEST; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; MYOCARDIUM; TISSUE SURVIVAL;

EID: 43649107724     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2008.02.005     Document Type: Article

References (81)

1. Yusuf S., Reddy S., Ounpuu S., et al. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104 22 (2001) 2746-2753
2. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 5 (2007) e69-e171
3. Nesto R.W., and Kowalchuk G.J. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 59 7 (1987) C23-C30
4. Prasad S.K.L.J., Chai P., and Gatehouse P. Role of CMR in assessment of myocardial perfusion. Eur Radiol 15 suppl 2 (2005) B42-B47
5. Bax J.J., Visser F.C., Poldermans D., et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 104 90001 (2001) I314-I318
6. Gowda R.M., Khan I.A., Vasavada B.C., et al. Reversible myocardial dysfunction: basics and evaluation. Int J Cardiol 97 3 (2004) 349-353
7. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 7 (2005) 1104-1108
8. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 19 (1999) 1992-2002
9. Fieno D.S., Kim R.J., Chen E.-L., et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36 6 (2000) 1985-1991
10. Peukert D., Laule M., Taupitz M., et al. 3D and 2D delayed-enhancement magnetic resonance imaging for detection of myocardial infarction: preclinical and clinical results. Acad Radiol 14 7 (2007) 788-794
11. Ovize M.R.D., de Lorgeril M., Pichard J.B., et al. Quantitation of reperfused myocardial infarction by Gd-DOTA-enhanced magnetic resonance imaging. An experimental study. Invest Radiol 26 12 (1991) 1065-1070
12. Schulz-Menger J., Gross M., Messroghli D., et al. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 42 3 (2003) 513-518
13. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 1 (2001) 215-223
14. Gupta A., Lee V.S., Chung Y.-C., et al. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology 233 3 (2004) 921-926
15. Kellman P., and Arai A.E. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47 2 (2002) 372-383
16. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 20 (2000) 1445-1453
17. Beek A.M., Kuhl H.P., Bondarenko O., et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 42 5 (2003) 895-901
18. Biagini E., van Geuns R.J., Baks T., et al. Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention. Am J Cardiol 97 3 (2006) 361-366
19. Gerber B.L., Garot J., Bluemke D.A., et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 9 (2002) 1083-1089
20. Selvanayagam J.B., Kardos A., Francis J.M., et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110 12 (2004) 1535-1541
21. Choi K.M., Kim R.J., Gubernikoff G., et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 10 (2001) 1101-1107
22. Hombach V., Grebe O., Merkle N., et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26 6 (2005) 549-557
23. Bello D., Shah D.J., Farah G.M., et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108 16 (2003) 1945-1953
24. Kwong R.Y., Chan A.K., Brown K.A., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 23 (2006) 2733-2743
25. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 1 (2006) 32-39
26. Lim R.P., Srichai M.B., and Lee V.S. Non-ischemic causes of delayed myocardial hyperenhancement on MRI. AJR Am J Roentgenol 188 6 (2007) 1675-1681
27. Klein C., Nekolla S.G., Bengel F.M., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 2 (2002) 162-167
28. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 61 9355 (2003) 374-379
29. Lund G.K., Stork A., Saeed M., et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 232 1 (2004) 49-57
30. Gutberlet M.F.M., Mehl S., Amthauer H., et al. Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Eur Radiol 15 5 (2005) 872-880
31. Hendel R.C., Jamil T., and Glover D.K. Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol 10 2 (2003) 197-204
32. Tulevski II, van der Wall E.E., Groenink M., et al. Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol 89 9 (2002) 1077-1081
33. Dymarkowski S.S.M., Maes A., Liu X.S., et al. Assessment of myocardial viability in a porcine model of chronic coronary artery stenosis with dual dose dobutamine magnetic resonance imaging. Int J Cardiovasc Imaging 19 1 (2003) 63-72
34. Kuijpers D.J.C., van Dijkman P.R., and Oudkerk M. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol 14 10 (2004) 1823-1828
35. Raman S. Dobutamine stress magnetic resonance imaging. Emerg Radiol 9 5 (2002) 289-291
36. Muehling O.M.H.A., Friedrich D., Nabauer M., et al. Code blue in the MR suite-a drill to rescue a patients with cardiac arrest from the MR scanner. Int J Cardiovasc Imaging 22 2 (2006) 257-261
37. Miyamoto M.I., Vernotico S.L., Majmundar H., et al. Pharmacologic stress myocardial perfusion imaging: a practical approach. J Nucl Cardiol 14 2 (2007) 250-255
38. Dendale P., Franken P.R., Holman E., et al. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 82 3 (1998) 375-377
39. Geskin G., Kramer C.M., Rogers W.J., et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 98 3 (1998) 217-223
40. Sandstede J.J.W., Bertsch G., Beer M., et al. Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 17 10 (1999) 1437-1443
41. Rerkpattanapipat P., Little W.C., Clark H.P., et al. Effect of the transmural extent of myocardial scar on left ventricular systolic wall thickening during intravenous dobutamine administration. Am J Cardiol 95 4 (2005) 495-498
42. Wellnhofer E., Olariu A., Klein C., et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 109 18 (2004) 2172-2174
43. Bove C.M., DiMaria J.M., Voros S., et al. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology 240 3 (2006) 835-841
44. Paetsch I., Jahnke C., Wahl A., et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110 7 (2004) 835-842
45. van Dijkman P.R.M., Kuijpers D.A., Blom B.M., et al. Dobutamine stress magnetic resonance imaging: a valuable method in the noninvasive diagnosis of ischemic heart disease. J Electrocardiol 35 4 Pt 2 (2002) 57-59
46. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99 6 (1999) 763-770
47. Nandalur K.R., Dwamena B.A., Choudhri A.F., et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50 14 (2007) 1343-1353
48. Hundley W.G., Hamilton C.A., Thomas M.S., et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100 16 (1999) 1697-1702
49. Hundley W.G., Morgan T.M., Neagle C.M., et al. Magnetic resonance imaging determination of cardiac prognosis. Circulation 106 18 (2002) 2328-2333
50. Jahnke C., Nagel E., Gebker R., et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115 13 (2007) 1769-1776
51. Syed M.A., Paterson D.I., Ingkanisorn W.P., et al. Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research. J Cardiovasc Magn Reson 7 5 (2005) 763-768
52. Paetsch I., Jahnke C., Ferrari V.A., et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 27 12 (2006) 1459-1464
53. Kuijpers D., Ho K.Y., van Dijkman P.R., et al. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 107 12 (2003) 1592-1597
54. White M.P. Pharmacologic stress testing: understanding the options. J Nucl Cardiol 6 6 (1999) 672-675
55. Cerqueira M.D., Verani M.S., Schwaiger M., et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23 2 (1994) 384-389
56. Gebker R., Schwitter J., Fleck E., et al. How we perform myocardial perfusion with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 9 3 (2007) 539-547
57. Kim H.W., Klem I., and Kim R.J. Detection of myocardial ischemia by stress perfusion cardiovascular magnetic resonance. Cardiol Clin 25 1 (2007) 57-70 vi
58. Klem I., Heitner J.F., Shah D.J., et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47 8 (2006) 1630-1638
59. Futamatsu H.K.C., Pilla M., Wilke N., et al. Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography. Int J Cardiovasc Imaging (2007) Sep 11 (Epub ahead of print)
60. Fenchel M., Helber U., Kramer U., et al. Detection of regional myocardial perfusion deficit using rest and stress perfusion MRI: a feasibility study. AJR Am J Roentgenol 185 3 (2005) 627-635
61. Plein S., Radjenovic A., Ridgway J.P., et al. Coronary artery disease: myocardial perfusion mr imaging with sensitivity encoding versus conventional angiography. Radiology 235 2 (2005) 423-430
62. Al-Saadi N., Nagel E., Gross M., et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101 12 (2000) 1379-1383
63. Chiu C.W., So N.M., Lam W.W., et al. Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study. Radiology 226 3 (2003) 717-722
64. Doyle M., Fuisz A., Kortright E., et al. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson 5 3 (2003) 475-485
65. Giang T.H., Nanz D., Coulden R., et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 25 18 (2004) 1657-1665
66. Ibrahim T., Nekolla S.G., Schreiber K., et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 39 5 (2002) 864-870
67. Ishida N., Sakuma H., Motoyasu M., et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 229 1 (2003) 209-216
68. Klein M.A., Collier B.D., Hellman R.S., et al. Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo-fast low-angle shot MR images. AJR Am J Roentgenol 161 2 (1993) 257-263
69. Nagel E., Klein C., Paetsch I., et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108 4 (2003) 432-437
70. Paetsch I., Jahnke C., Wahl A., et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 110 7 (2004) 835-842
71. Panting J.R., Gatehouse P.D., Yang G.Z., et al. Echo-planar magnetic resonance myocardial perfusion imaging: parametric map analysis and comparison with thallium SPECT. J Magn Reson Imaging 13 2 (2001) 192-200
72. Plein S., Greenwood J.P., Ridgway J.P., et al. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J AmColl Cardiol 44 11 (2004) 2173-2181
73. Plein S., Radjenovic A., Ridgway J.P., et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 235 2 (2005) 423-430
74. Schwitter J., Nanz D., Kneifel S., et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103 18 (2001) 2230-2235
75. Sensky P.R., Samani N.J., Reek C., et al. Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach. Int J Cardiovasc Imaging 18 5 (2002) 373-383 discussion 385-376
76. Wolff S.D., Schwitter J., Coulden R., et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 110 6 (2004) 732-737
77. Panting J.R., Gatehouse P.D., and Yang G.Z. Echo-planar magnetic resonance myocardial perfusion imaging: parametric map analysis and comparison with thallium SPECT. J Magn Reson Imaging 13 2 (2001) 192-200
78. Beller G.A., and Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 101 12 (2000) 1465-1478
79. Ingkanisorn W.P., Kwong R.Y., Bohme N.S., et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J AmColl Cardiol 47 7 (2006) 1427-1432
80. Hendel R.C., Patel M.R., Kramer C.M., et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 Appropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging: A Report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48 7 (2006) 1475-1497
81. Cury R.C., Cattani C.A., Gabure L.A., et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240 1 (2006) 39-45